Clinical Trial Update: Nivolumab, Ipilimumab and Chemoradiation in Pancreatic Cancer. [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update notes the completion of a Phase 1/2 study evaluating nivolumab and ipilimumab in combination with chemoradiation for borderline resec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Herlev Hospital | Conditions: Borderline Resectable, Locally Advanced or Metastatic Pancreatic Cancer | Phase 1, Phase 2 | Status: COMPLETED